UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinico-Hematological Patterns of Patients Presenting With Erythrocytosis

Pakistan Armed Forces medical journal, 2024-02, Vol.74 (1), p.3-7

2024

Volltextzugriff (PDF)

A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline

British journal of haematology, 2019-01, Vol.184 (2), p.176-191

2019

Volltextzugriff (PDF)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline

British journal of haematology, 2019-01, Vol.184 (2), p.161-175

2019

Volltextzugriff (PDF)

JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen

Aktuelle Rheumatologie, 2020-12, Vol.45 (6), p.559-567

2020

Volltextzugriff (PDF)

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study

British journal of haematology, 2024-05, Vol.204 (5), p.1740-1751

2024

Volltextzugriff (PDF)

Distribution and Aetiology of Thrombocytosis in Inpatients Setting of a Tertiary Care Hospital: A Cross-section Study from Western Maharashtra, India

Journal of clinical and diagnostic research, 2023-07, Vol.17 (7), p.50-53

2023

Volltextzugriff (PDF)

Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?

British journal of haematology, 2023-10, Vol.203 (2), p.169-181

2023

Volltextzugriff (PDF)

Profile of polycythaemia vera in South Western Nigeria

Nigerian journal of medicine, 2022-07, Vol.31 (4), p.462-466

2022

Volltextzugriff (PDF)

A journey through infectious risk associated with ruxolitinib

British journal of haematology, 2019-11, Vol.187 (3), p.286-295

2019

Volltextzugriff (PDF)

Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2023-02, Vol.30 (1), p.63-68

2023

Volltextzugriff (PDF)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

British journal of haematology, 2017-01, Vol.176 (1), p.76-85

2017

Volltextzugriff (PDF)

Myeloproliferative neoplasms in adolescents and young adults

Best practice & research. Clinical haematology, 2022-06, Vol.35 (2), p.101374-101374, Article 101374

2022

Volltextzugriff (PDF)

Exposure–efficacy and exposure–safety analyses of ropeginterferon alfa‐2b treatment in patients with polycythaemia vera

British journal of clinical pharmacology, 2024-06, Vol.90 (6), p.1493-1502

2024

Volltextzugriff (PDF)

A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera

British journal of haematology, 2014-11, Vol.167 (4), p.541-546

2014

Volltextzugriff (PDF)

How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy

British journal of haematology, 2020-05, Vol.189 (4), p.625-634

2020

Volltextzugriff (PDF)

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients

Hematology, Transfusion and Cell Therapy, 2024-10, Vol.46 (4), p.393-396

2024

Volltextzugriff (PDF)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)

Leukemia research reports, 2023-01, Vol.19, p.100360, Article 100360

2023

Volltextzugriff (PDF)

Application of an NGS‐based 28‐gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera

British journal of haematology, 2016-11, Vol.175 (3), p.419-426

2016

Volltextzugriff (PDF)

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

British journal of haematology, 2016-03, Vol.172 (5), p.786-793

2016

Volltextzugriff (PDF)

Molecular pathogenesis of the myeloproliferative neoplasms

Journal of hematology and oncology, 2021-06, Vol.14 (1), p.1-103, Article 103

2021

Volltextzugriff (PDF)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis

British journal of haematology, 2019-01, Vol.184 (2), p.161-175

2019

Volltextzugriff (PDF)

Smoking, blood cells and myeloproliferative neoplasms: meta‐analysis and Mendelian randomization of 2·3 million people

British journal of haematology, 2020-04, Vol.189 (2), p.323-334

2020

Volltextzugriff (PDF)

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

British journal of haematology, 2005-07, Vol.130 (2), p.174-195

2005

Volltextzugriff (PDF)

Characterization of myeloproliferative neoplasms in the paediatric and young adult population

British journal of haematology, 2023-05, Vol.201 (3), p.449-458

2023

Volltextzugriff (PDF)

Multifocal Mycobacterium kansasii osteomyelitis in a patient on ruxolitinib

Clinical infection in practice, 2022-01, Vol.13, p.100124, Article 100124

2022

Volltextzugriff (PDF)

1 – 25 von 396

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(288)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Polycythaemia Vera
(340)
Humans
(277)
Science & Technology
(255)
Life Sciences & Biomedicine
(254)
Hematology
(191)
Female
(173)
Male
(164)
Middle Aged
(146)
Aged
(137)
Biological And Medical Sciences
(132)
Medical Sciences
(132)
Adult
(121)
Essential Thrombocythaemia
(105)
Hematologic And Hematopoietic Diseases
(105)
Polycythemia Vera - Blood
(72)
Myelofibrosis
(70)
Aged, 80 And Over
(63)
Diseases Of Red Blood Cells
(61)
Polycythemia Vera - Complications
(61)
Mutation
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinico-Hematological Patterns of Patients Presenting With Erythrocytosis

A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline

JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study

Distribution and Aetiology of Thrombocytosis in Inpatients Setting of a Tertiary Care Hospital: A Cross-section Study from Western Maharashtra, India

Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?

Profile of polycythaemia vera in South Western Nigeria

A journey through infectious risk associated with ruxolitinib

Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)

Myeloproliferative neoplasms in adolescents and young adults

Exposure–efficacy and exposure–safety analyses of ropeginterferon alfa‐2b treatment in patients with polycythaemia vera

A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera

How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)

Application of an NGS‐based 28‐gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

Molecular pathogenesis of the myeloproliferative neoplasms

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis

Smoking, blood cells and myeloproliferative neoplasms: meta‐analysis and Mendelian randomization of 2·3 million people

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis

Characterization of myeloproliferative neoplasms in the paediatric and young adult population

Multifocal Mycobacterium kansasii osteomyelitis in a patient on ruxolitinib

Suchergebnisse filtern